Genetic insights on host and hepatitis b virus in liver diseases

Mutation Research - Reviews in Mutation Research

Volumn 762, Issue , 2014, Pages 65-75

  Tong, Hoang Van ^a   Thomas Bock, C ^b   Velavan, Thirumalaisamy P ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Genome wide association studies; Hepatitis b virus; Hepatocellular carcinoma; Host genetics; Liver disease; Next generation sequencing

Indexed keywords

BETA CATENIN; DEP DOMAIN CONTAINING 5; HEPATITIS B VACCINE; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; JANUS KINASE; KINESIN FAMILY MEMBER 1B; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I CHAIN RELATED GENE A; PATATIN LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN P53; STAT PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG; WNT PROTEIN;

ANTIVIRAL RESISTANCE; CHROMATIN; CPG ISLAND; DISEASE COURSE; DNA INTEGRATION; DNA METHYLATION; ETHNIC GROUP; EXOME; GENE MUTATION; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC VARIABILITY; GENOME; HEPATITIS B; HEPATITIS B VIRUS; HEREDITY; HLA SYSTEM; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; REGULATOR GENE; REVIEW; RNA SEQUENCE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; TREATMENT RESPONSE; VIRAL GENETICS; VIRUS CELL INTERACTION; ANIMAL; GENETICS; HUMAN GENOME; MUTATION; PATHOLOGY; PROCEDURES; VIROLOGY; VIRUS GENE;

HEPATITIS B VIRUS;

ANIMALS; GENES, VIRAL; GENETIC ASSOCIATION STUDIES; GENOME, HUMAN; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER DISEASES; MUTATION;

EID: 84919634455     PISSN: 13835742     EISSN: 13882139     Source Type: Journal    
DOI: 10.1016/j.mrrev.2014.06.001     Document Type: Review

References (124)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral Hepat. 2004, 11:97-107.
2. Liaw Y.F., Chu C.M. Hepatitis B virus infection. Lancet 2009, 373:582-592.
3. Lee W.M. Hepatitis B virus infection. N. Engl. J. Med. 1997, 337:1733-1745.
4. Schuppan D., Afdhal N.H. Liver cirrhosis. Lancet 2008, 371:838-851.
5. Yim H.J., Lok A.S. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 2006, 43:S173-S181.
6. Di A.M., Bisceglie Hepatitis B and hepatocellular carcinoma. Hepatology 2009, 49:S56-S60.
7. Bosch F.X., Ribes J., Diaz M., Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004, 127:S5-S16.
8. Llovet J.M., Burroughs A., Bruix J. Hepatocellular carcinoma. Lancet 2003, 362:1907-1917.
9. Nguyen V.T., Law M.G., Dore G.J. Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden. J. Viral Hepat. 2009, 16:453-463.
10. El-Serag H.B. Hepatocellular carcinoma. N. Engl. J. Med. 2011, 365:1118-1127.
11. Karlsen T.H., Melum E., Franke A. The utility of genome-wide association studies in hepatology. Hepatology 2010, 51:1833-1842.
12. Sachidanandam R., Weissman D., Schmidt S.C., Kakol J.M., Stein L.D., Marth G., Sherry S., Mullikin J.C., Mortimore B.J., Willey D.L., Hunt S.E., Cole C.G., Coggill P.C., Rice C.M., Ning Z., Rogers J., Bentley D.R., Kwok P.Y., Mardis E.R., Yeh R.T., Schultz B., Cook L., Davenport R., Dante M., Fulton L., Hillier L., Waterston R.H., McPherson J.D., Gilman B., Schaffner S., Van Etten W.J., Reich D., Higgins J., Daly M.J., Blumenstiel B., Baldwin J., Stange-Thomann N., Zody M.C., Linton L., Lander E.S., Altshuler D. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001, 409:928-933.
13. Chapman S.J., Hill A.V. Human genetic susceptibility to infectious disease. Nat. Rev. Genet. 2012, 13:175-188.
14. Bush W.S., Moore J.H. Chapter 11: Genome-wide association studies. PLoS Comput. Biol. 2012, 8:e1002822.
15. Hindorff L.A., Sethupathy P., Junkins H.A., Ramos E.M., Mehta J.P., Collins F.S., Manolio T.A. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:9362-9367.
16. Chotiyaputta W., Lok A.S. Hepatitis B virus variants. Nat. Rev. Gastroenterol. Hepatol. 2009, 6:453-462.
17. Ganem D., Prince A.M. Hepatitis B virus infection - natural history and clinical consequences. N. Engl. J. Med. 2004, 350:1118-1129.
18. Norder H., Courouce A.M., Coursaget P., Echevarria J.M., Lee S.D., Mushahwar I.K., Robertson B.H., Locarnini S., Magnius L.O. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 2004, 47:289-309.
19. Kramvis A., Kew M., Francois G. Hepatitis B virus genotypes. Vaccine 2005, 23:2409-2423.
20. Kramvis A., Arakawa K., Yu M.C., Nogueira R., Stram D.O., Kew M.C. Relationship of serological subtype, basic core promoter and precore mutations to genotypes/subgenotypes of hepatitis B virus. J. Med. Virol. 2008, 80:27-46.
21. Chen B.F., Kao J.H., Liu C.J., Chen D.S., Chen P.J. Genotypic dominance and novel recombinations in HBV genotype B and C co-infected intravenous drug users. J. Med. Virol. 2004, 73:13-22.
22. Kao J.H., Chen P.J., Lai M.Y., Chen D.S. Clinical and virological aspects of blood donors infected with hepatitis B virus genotypes B and C. J. Clin. Microbiol. 2002, 40:22-25.
23. El-Serag H.B. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012, 142:1264-1273.
24. Yang H.I., Yeh S.H., Chen P.J., Iloeje U.H., Jen C.L., Su J., Wang L.Y., Lu S.N., You S.L., Chen D.S., Liaw Y.F., Chen C.J. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J. Natl. Cancer Inst. 2008, 100:1134-1143.
25. Mahtab M.A., Rahman S., Khan M., Karim F. Hepatitis B virus genotypes: an overview. Hepatobiliary Pancreat. Dis. Int. 2008, 7:457-464.
26. Huang Y., Lok A.S. Viral factors and outcomes of chronic HBV infection. Am. J. Gastroenterol. 2011, 106:93-95.
27. McMahon B.J. Epidemiology and natural history of hepatitis B. Semin. Liver Dis. 2005, 25(Suppl. 1):3-8.
28. Kramvis A., Kew M.C. Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy. J. Viral Hepat. 2005, 12:456-464.
29. Rodriguez-Frias F., Buti M., Jardi R., Cotrina M., Viladomiu L., Esteban R., Guardia J. Hepatitis B virus infection: precore mutants and its relation to viral genotypes and core mutations. Hepatology 1995, 22:1641-1647.
30. Jardi R., Rodriguez F., Buti M., Costa X., Valdes A., Allende H., Schaper M., Galimany R., Esteban R., Guardia J. Mutations in the basic core promoter region of hepatitis B virus. Relationship with precore variants and HBV genotypes in a Spanish population of HBV carriers. J. Hepatol. 2004, 40:507-514.
31. Yin J., Xie J., Liu S., Zhang H., Han L., Lu W., Shen Q., Xu G., Dong H., Shen J., Zhang J., Han J., Wang L., Liu Y., Wang F., Zhao J., Zhang Q., Ni W., Wang H., Cao G. Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma. Am. J. Gastroenterol. 2011, 106:81-92.
32. Pollicino T., Saitta C., Raimondo G. Hepatocellular carcinoma: the point of view of the hepatitis B virus. Carcinogenesis 2011, 32:1122-1132.
33. Norder H., Arauz-Ruiz P., Blitz L., Pujol F.H., Echevarria J.M., Magnius L.O. The T(1858) variant predisposing to the precore stop mutation correlates with one of two major genotype F hepatitis B virus clades. J. Gen. Virol. 2003, 84:2083-2087.
34. Chen W.N., Oon C.J. Hepatitis B virus mutants: an overview. J. Gastroenterol. Hepatol. 2002, 17(Suppl.):S497-S499.
35. Pawlotsky J.M. The concept of hepatitis B virus mutant escape. J. Clin. Virol. 2005, 34(Suppl. 1):S125-S129.
36. Raimondo G., Caccamo G., Filomia R., Pollicino T. Occult HBV infection. Semin. Immunopathol. 2013, 35:39-52.
37. Sugauchi F., Ohno T., Orito E., Sakugawa H., Ichida T., Komatsu M., Kuramitsu T., Ueda R., Miyakawa Y., Mizokami M. Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver disease. J. Med. Virol. 2003, 70:537-544.
38. Brookes A.J. The essence of SNPs. Gene 1999, 234:177-186.
39. Kamatani Y., Wattanapokayakit S., Ochi H., Kawaguchi T., Takahashi A., Hosono N., Kubo M., Tsunoda T., Kamatani N., Kumada H., Puseenam A., Sura T., Daigo Y., Chayama K., Chantratita W., Nakamura Y., Matsuda K. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat. Genet. 2009, 41:591-595.
40. An P., Winkler C., Guan L., O'Brien S.J., Zeng Z. A common HLA-DPA1 variant is a major determinant of hepatitis B virus clearance in Han Chinese. J. Infect. Dis. 2011, 203:943-947.
41. Wong D.K., Watanabe T., Tanaka Y., Seto W.K., Lee C.K., Fung J., Lin C.K., Huang F.Y., Lai C.L., Yuen M.F. Role of HLA-DP polymorphisms on chronicity and disease activity of hepatitis B infection in Southern Chinese. PLOS ONE 2013, 8:e66920.
42. Guo X., Zhang Y., Li J., Ma J., Wei Z., Tan W., O'Brien S.J. Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population. Hepatology 2011, 53:422-428.
43. Wang L., Wu X.P., Zhang W., Zhu D.H., Wang Y., Li Y.P., Tian Y., Li R.C., Li Z., Zhu X., Li J.H., Cai J., Liu L., Miao X.P., Liu Y., Li H. Evaluation of genetic susceptibility loci for chronic hepatitis B in Chinese: two independent case-control studies. PLOS ONE 2011, 6:e17608.
44. Hu L., Zhai X., Liu J., Chu M., Pan S., Jiang J., Zhang Y., Wang H., Chen J., Shen H., Hu Z. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hepatology 2012, 55:1426-1431.
45. Nishida N., Sawai H., Matsuura K., Sugiyama M., Ahn S.H., Park J.Y., Hige S., Kang J.H., Suzuki K., Kurosaki M., Asahina Y., Mochida S., Watanabe M., Tanaka E., Honda M., Kaneko S., Orito E., Itoh Y., Mita E., Tamori A., Murawaki Y., Hiasa Y., Sakaida I., Korenaga M., Hino K., Ide T., Kawashima M., Mawatari Y., Sageshima M., Ogasawara Y., Koike A., Izumi N., Han K.H., Tanaka Y., Tokunaga K., Mizokami M. Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean. PLOS ONE 2012, 7:e39175.
46. O'Brien T.R., Kohaar I., Pfeiffer R.M., Maeder D., Yeager M., Schadt E.E., Prokunina-Olsson L. Risk alleles for chronic hepatitis B are associated with decreased mRNA expression of HLA-DPA1 and HLA-DPB1 in normal human liver. Genes Immun. 2011, 12:428-433.
47. Mbarek H., Ochi H., Urabe Y., Kumar V., Kubo M., Hosono N., Takahashi A., Kamatani Y., Miki D., Abe H., Tsunoda T., Kamatani N., Chayama K., Nakamura Y., Matsuda K. A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum. Mol. Genet. 2011, 20:3884-3892.
48. Kim Y.J., Kim H.Y., Lee J.H., Yu S.J., Yoon J.H., Lee H.S., Kim C.Y., Cheong J.Y., Cho S.W., Park N.H., Park B.L., Namgoong S., Kim L.H., Cheong H.S., Shin H.D. Genome-wide association study identified new variants associated with the risk of chronic hepatitis B. Hum. Mol. Genet. 2013, 22:4233-4238.
49. Thursz M.R., Kwiatkowski D., Allsopp C.E., Greenwood B.M., Thomas H.C., Hill A.V. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N. Engl. J. Med. 1995, 332:1065-1069.
50. Ahn S.H., Han K.H., Park J.Y., Lee C.K., Kang S.W., Chon C.Y., Kim Y.S., Park K., Kim D.K., Moon Y.M. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology 2000, 31:1371-1373.
51. Hu Z., Liu Y., Zhai X., Dai J., Jin G., Wang L., Zhu L., Yang Y., Liu J., Chu M., Wen J., Xie K., Du G., Wang Q., Zhou Y., Cao M., Liu L., He Y., Wang Y., Zhou G., Jia W., Lu J., Li S., Liu J., Yang H., Shi Y., Zhou W., Shen H. New loci associated with chronic hepatitis B virus infection in Han Chinese. Nat. Genet. 2013, 45:1499-1503.
52. Davila S., Froeling F.E., Tan A., Bonnard C., Boland G.J., Snippe H., Hibberd M.L., Seielstad M. New genetic associations detected in a host response study to hepatitis B vaccine. Genes Immun. 2010, 11:232-238.
53. Png E., Thalamuthu A., Ong R.T., Snippe H., Boland G.J., Seielstad M. A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region. Hum. Mol. Genet. 2011, 20:3893-3898.
54. Wang C., Tang J., Song W., Lobashevsky E., Wilson C.M., Kaslow R.A. HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatology 2004, 39:978-988.
55. Wu T.W., Chu C.C., Ho T.Y., Chang Liao H.W., Lin S.K., Lin M., Lin H.H., Wang L.Y. Responses to booster hepatitis B vaccination are significantly correlated with genotypes of human leukocyte antigen (HLA)-DPB1 in neonatally vaccinated adolescents. Hum. Genet. 2013, 132:1131-1139.
56. Pan L., Zhang L., Zhang W., Wu X., Li Y., Yan B., Zhu X., Liu X., Yang C., Xu J., Zhou G., Xu A., Li H., Liu Y. A genome-wide association study identifies polymorphisms in the HLA-DR region associated with non-response to hepatitis B vaccination in Chinese han populations. Hum. Mol. Genet. 2014, 23:2210-2219.
57. Hirschfield G.M., Liu X., Xu C., Lu Y., Xie G., Lu Y., Gu X., Walker E.J., Jing K., Juran B.D., Mason A.L., Myers R.P., Peltekian K.M., Ghent C.N., Coltescu C., Atkinson E.J., Heathcote E.J., Lazaridis K.N., Amos C.I., Siminovitch K.A. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N. Engl. J. Med. 2009, 360:2544-2555.
58. Clifford R.J., Zhang J., Meerzaman D.M., Lyu M.S., Hu Y., Cultraro C.M., Finney R.P., Kelley J.M., Efroni S., Greenblum S.I., Nguyen C.V., Rowe W.L., Sharma S., Wu G., Yan C., Zhang H., Chung Y.H., Kim J.A., Park N.H., Song I.H., Buetow K.H. Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma. Hepatology 2010, 52:2034-2043.
59. Patin E., Kutalik Z., Guergnon J., Bibert S., Nalpas B., Jouanguy E., Munteanu M., Bousquet L., Argiro L., Halfon P., Boland A., Mullhaupt B., Semela D., Dufour J.F., Heim M.H., Moradpour D., Cerny A., Malinverni R., Hirsch H., Martinetti G., Suppiah V., Stewart G., Booth D.R., George J., Casanova J.L., Brechot C., Rice C.M., Talal A.H., Jacobson I.M., Bourliere M., Theodorou I., Poynard T., Negro F., Pol S., Bochud P.Y., Abel L. Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection. Gastroenterology 2012, 143:1244-1252.
60. Huang H., Shiffman M.L., Cheung R.C., Layden T.J., Friedman S., Abar O.T., Yee L., Chokkalingam A.P., Schrodi S.J., Chan J., Catanese J.J., Leong D.U., Ross D., Hu X., Monto A., McAllister L.B., Broder S., White T., Sninsky J.J., Wright T.L. Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C. Gastroenterology 2006, 130:1679-1687.
61. Huang H., Shiffman M.L., Friedman S., Venkatesh R., Bzowej N., Abar O.T., Rowland C.M., Catanese J.J., Leong D.U., Sninsky J.J., Layden T.J., Wright T.L., White T., Cheung R.C. A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Hepatology 2007, 46:297-306.
62. Urabe Y., Ochi H., Kato N., Kumar V., Takahashi A., Muroyama R., Hosono N., Otsuka M., Tateishi R., Lo P.H., Tanikawa C., Omata M., Koike K., Miki D., Abe H., Kamatani N., Toyota J., Kumada H., Kubo M., Chayama K., Nakamura Y., Matsuda K. A genome-wide association study of HCV-induced liver cirrhosis in the Japanese population identifies novel susceptibility loci at the MHC region. J. Hepatol. 2013, 58:875-882.
63. Trepo E., Pradat P., Potthoff A., Momozawa Y., Quertinmont E., Gustot T., Lemmers A., Berthillon P., Amininejad L., Chevallier M., Schlue J., Kreipe H., Deviere J., Manns M., Trepo C., Sninsky J., Wedemeyer H., Franchimont D., Moreno C. Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C. Hepatology 2011, 54:60-69.
64. Zhang H., Zhai Y., Hu Z., Wu C., Qian J., Jia W., Ma F., Huang W., Yu L., Yue W., Wang Z., Li P., Zhang Y., Liang R., Wei Z., Cui Y., Xie W., Cai M., Yu X., Yuan Y., Xia X., Zhang X., Yang H., Qiu W., Yang J., Gong F., Chen M., Shen H., Lin D., Zeng Y.X., He F., Zhou G. Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat. Genet. 2010, 42:755-758.
65. Schlisio S., Kenchappa R.S., Vredeveld L.C., George R.E., Stewart R., Greulich H., Shahriari K., Nguyen N.V., Pigny P., Dahia P.L., Pomeroy S.L., Maris J.M., Look A.T., Meyerson M., Peeper D.S., Carter B.D., Kaelin W.G. The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes Dev. 2008, 22:884-893.
66. Al-Qahtani A., Al-Anazi M., Viswan N.A., Khalaf N., Abdo A.A., Sanai F.M., Al-Ashgar H., Al-Ahdal M. Role of single nucleotide polymorphisms of KIF1B gene in HBV-associated viral hepatitis. PLOS ONE 2012, 7:e45128.
67. Sopipong W., Tangkijvanich P., Payungporn S., Posuwan N., Poovorawan Y. The KIF1B (rs17401966) single nucleotide polymorphism is not associated with the development of HBV-related hepatocellular carcinoma in Thai patients. Asian Pac. J. Cancer Prev. 2013, 14:2865-2869.
68. Sawai H., Nishida N., Mbarek H., Matsuda K., Mawatari Y., Yamaoka M., Hige S., Kang J.H., Abe K., Mochida S., Watanabe M., Kurosaki M., Asahina Y., Izumi N., Honda M., Kaneko S., Tanaka E., Matsuura K., Itoh Y., Mita E., Korenaga M., Hino K., Murawaki Y., Hiasa Y., Ide T., Ito K., Sugiyama M., Ahn S.H., Han K.H., Park J.Y., Yuen M.F., Nakamura Y., Tanaka Y., Mizokami M., Tokunaga K. No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations. BMC Med. Genet. 2012, 13:47.
69. Aulchenko Y.S., Hoppenbrouwers I.A., Ramagopalan S.V., Broer L., Jafari N., Hillert J., Link J., Lundstrom W., Greiner E., Dessa S.A., Goossens D., Van B.C., Del-Favero J., Ebers G.C., Oostra B.A., van Duijn C.M., Hintzen R.Q. Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis. Nat. Genet. 2008, 40:1402-1403.
70. Zhong R., Tian Y., Liu L., Qiu Q., Wang Y., Rui R., Yang B.F., Duan S.Y., Shi J.X., Miao X.P., Wang L., Li H. HBV-related hepatocellular carcinoma susceptibility gene KIF1B is not associated with development of chronic hepatitis B. PLOS ONE 2012, 7:e28839.
71. Chan K.Y., Wong C.M., Kwan J.S., Lee J.M., Cheung K.W., Yuen M.F., Lai C.L., Poon R.T., Sham P.C., Ng I.O. Genome-wide association study of hepatocellular carcinoma in Southern Chinese patients with chronic hepatitis B virus infection. PLOS ONE 2011, 6:e28798.
72. Ng I.O., Liang Z.D., Cao L., Lee T.K. DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1. Cancer Res. 2000, 60:6581-6584.
73. Wong C.M., Lee J.M., Ching Y.P., Jin D.Y., Ng I.O. Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma. Cancer Res. 2003, 63:7646-7651.
74. Li S., Qian J., Yang Y., Zhao W., Dai J., Bei J.X., Foo J.N., McLaren P.J., Li Z., Yang J., Shen F., Liu L., Yang J., Li S., Pan S., Wang Y., Li W., Zhai X., Zhou B., Shi L., Chen X., Chu M., Yan Y., Wang J., Cheng S., Shen J., Jia W., Liu J., Yang J., Wen Z., Li A., Zhang Y., Zhang G., Luo X., Qin H., Chen M., Wang H., Jin L., Lin D., Shen H., He L., de Bakker P.I., Wang H., Zeng Y.X., Wu M., Hu Z., Shi Y., Liu J., Zhou W. GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS Genet. 2012, 8:e1002791.
75. Jiang D.K., Sun J., Cao G., Liu Y., Lin D., Gao Y.Z., Ren W.H., Long X.D., Zhang H., Ma X.P., Wang Z., Jiang W., Chen T.Y., Gao Y., Sun L.D., Long J.R., Huang H.X., Wang D., Yu H., Zhang P., Tang L.S., Peng B., Cai H., Liu T.T., Zhou P., Liu F., Lin X., Tao S., Wan B., Sai-Yin H.X., Qin L.X., Yin J., Liu L., Wu C., Pei Y., Zhou Y.F., Zhai Y., Lu P.X., Tan A., Zuo X.B., Fan J., Chang J., Gu X., Wang N.J., Li Y., Liu Y.K., Zhai K., Zhang H., Hu Z., Liu J., Yi Q., Xiang Y., Shi R., Ding Q., Zheng W., Shu X.O., Mo Z., Shugart Y.Y., Zhang X.J., Zhou G., Shen H., Zheng S.L., Xu J., Yu L. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat. Genet. 2013, 45:72-75.
76. Remmers E.F., Plenge R.M., Lee A.T., Graham R.R., Hom G., Behrens T.W., de Bakker P.I., Le J.M., Lee H.S., Batliwalla F., Li W., Masters S.L., Booty M.G., Carulli J.P., Padyukov L., Alfredsson L., Klareskog L., Chen W.V., Amos C.I., Criswell L.A., Seldin M.F., Kastner D.L., Gregersen P.K. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N. Engl. J. Med. 2007, 357:977-986.
77. Gao B., Wang H., Lafdil F., Feng D. STAT proteins - key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver. J. Hepatol. 2012, 57:430-441.
78. O'Shea J.J., Holland S.M., Staudt L.M. JAKs and STATs in immunity, immunodeficiency, and cancer. N. Engl. J. Med. 2013, 368:161-170.
79. Horras C.J., Lamb C.L., Mitchell K.A. Regulation of hepatocyte fate by interferon-gamma. Cytokine Growth Factor Rev. 2011, 22:35-43.
80. Clark A., Gerlach F., Tong H.V., Hoan N.X., Song L.H., Toan N.L., Bock C.T., Kremsner P.G., Velavan T.P. A trivial role of STAT4 variant in chronic hepatitis B induced hepatocellular carcinoma. Infect. Genet. Evol. 2013, 18C:257-261.
81. Galichon P., Hertig A., Rondeau E., Mesnard L. Warning: Genome-wide association studies can be misleading. An example in hepatology. Hepatology 2011, 53:1408-1409.
82. Kato N., Ji G., Wang Y., Baba M., Hoshida Y., Otsuka M., Taniguchi H., Moriyama M., Dharel N., Goto T., Shao R.X., Matsuura T., Ishii K., Shiina S., Kawabe T., Muramatsu M., Omata M. Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C. Hepatology 2005, 42:846-853.
83. Kumar V., Kato N., Urabe Y., Takahashi A., Muroyama R., Hosono N., Otsuka M., Tateishi R., Omata M., Nakagawa H., Koike K., Kamatani N., Kubo M., Nakamura Y., Matsuda K. Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma. Nat. Genet. 2011, 43:455-458.
84. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999, 285:727-729.
85. Groh V., Rhinehart R., Randolph-Habecker J., Topp M.S., Riddell S.R., Spies T. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2001, 2:255-260.
86. Groh V., Wu J., Yee C., Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 2002, 419:734-738.
87. Lo P.H., Urabe Y., Kumar V., Tanikawa C., Koike K., Kato N., Miki D., Chayama K., Kubo M., Nakamura Y., Matsuda K. Identification of a functional variant in the MICA promoter which regulates MICA expression and increases HCV-related hepatocellular carcinoma risk. PLOS ONE 2013, 8:e61279.
88. Kumar V., Yi Lo P.H., Sawai H., Kato N., Takahashi A., Deng Z., Urabe Y., Mbarek H., Tokunaga K., Tanaka Y., Sugiyama M., Mizokami M., Muroyama R., Tateishi R., Omata M., Koike K., Tanikawa C., Kamatani N., Kubo M., Nakamura Y., Matsuda K. Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma. PLOS ONE 2012, 7:e44743.
89. Miki D., Ochi H., Hayes C.N., Abe H., Yoshima T., Aikata H., Ikeda K., Kumada H., Toyota J., Morizono T., Tsunoda T., Kubo M., Nakamura Y., Kamatani N., Chayama K. Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers. Nat. Genet. 2011, 43:797-800.
90. Seng T.J., Ichimura K., Liu L., Tingby O., Pearson D.M., Collins V.P. Complex chromosome 22 rearrangements in astrocytic tumors identified using microsatellite and chromosome 22 tile path array analysis. Genes Chromosomes Cancer 2005, 43:181-193.
91. Iannacone M., Sitia G., Isogawa M., Marchese P., Castro M.G., Lowenstein P.R., Chisari F.V., Ruggeri Z.M., Guidotti L.G. Platelets mediate cytotoxic T lymphocyte-induced liver damage. Nat. Med. 2005, 11:1167-1169.
92. Maini M.K., Schurich A. Platelets harness the immune response to drive liver cancer. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:12840-12841.
93. Sitia G., Aiolfi R., Di L.P., Mainetti M., Fiocchi A., Mingozzi F., Esposito A., Ruggeri Z.M., Chisari F.V., Iannacone M., Guidotti L.G. Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:E2165-E2172.
94. Lange C.M., Bibert S., Dufour J.F., Cellerai C., Cerny A., Heim M.H., Kaiser L., Malinverni R., Mullhaupt B., Negro F., Semela D., Moradpour D., Kutalik Z., Bochud P.Y. Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma. J. Hepatol. 2013, 59:504-509.
95. Motomura T., Ono Y., Shirabe K., Fukuhara T., Konishi H., Mano Y., Toshima T., Yoshiya S., Muto J., Ikegami T., Yoshizumi T., Maehara Y. Neither MICA nor DEPDC5 genetic polymorphisms correlate with hepatocellular carcinoma recurrence following hepatectomy. HPB Surg. 2012, 2012:185496.
96. Romeo S., Kozlitina J., Xing C., Pertsemlidis A., Cox D., Pennacchio L.A., Boerwinkle E., Cohen J.C., Hobbs H.H. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 2008, 40:1461-1465.
97. Hassan M.M., Kaseb A., Etzel C.J., El-Serag H., Spitz M.R., Chang P., Hale K.S., Liu M., Rashid A., Shama M., Abbruzzese J.L., Loyer E.M., Kaur H., Hassabo H.M., Vauthey J.N., Wray C.J., Hassan B.S., Patt Y.Z., Hawk E., Soliman K.M., Li D. Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: Risk and prognosis prediction. Mol. Carcinog. 2013, 52(Suppl. 1):E139-E147.
98. Satow R., Shitashige M., Kanai Y., Takeshita F., Ojima H., Jigami T., Honda K., Kosuge T., Ochiya T., Hirohashi S., Yamada T. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma. Clin. Cancer Res. 2010, 16:2518-2528.
99. Li M., Zhao H., Zhang X., Wood L.D., Anders R.A., Choti M.A., Pawlik T.M., Daniel H.D., Kannangai R., Offerhaus G.J., Velculescu V.E., Wang L., Zhou S., Vogelstein B., Hruban R.H., Papadopoulos N., Cai J., Torbenson M.S., Kinzler K.W. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat. Genet. 2011, 43:828-829.
100. Totoki Y., Tatsuno K., Yamamoto S., Arai Y., Hosoda F., Ishikawa S., Tsutsumi S., Sonoda K., Totsuka H., Shirakihara T., Sakamoto H., Wang L., Ojima H., Shimada K., Kosuge T., Okusaka T., Kato K., Kusuda J., Yoshida T., Aburatani H., Shibata T. High-resolution characterization of a hepatocellular carcinoma genome. Nat. Genet. 2011, 43:464-469.
101. Fujimoto A., Totoki Y., Abe T., Boroevich K.A., Hosoda F., Nguyen H.H., Aoki M., Hosono N., Kubo M., Miya F., Arai Y., Takahashi H., Shirakihara T., Nagasaki M., Shibuya T., Nakano K., Watanabe-Makino K., Tanaka H., Nakamura H., Kusuda J., Ojima H., Shimada K., Okusaka T., Ueno M., Shigekawa Y., Kawakami Y., Arihiro K., Ohdan H., Gotoh K., Ishikawa O., Ariizumi S., Yamamoto M., Yamada T., Chayama K., Kosuge T., Yamaue H., Kamatani N., Miyano S., Nakagama H., Nakamura Y., Tsunoda T., Shibata T., Nakagawa H. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat. Genet. 2012, 44:760-764.
102. Guichard C., Amaddeo G., Imbeaud S., Ladeiro Y., Pelletier L., Maad I.B., Calderaro J., Bioulac-Sage P., Letexier M., Degos F., Clement B., Balabaud C., Chevet E., Laurent A., Couchy G., Letouze E., Calvo F., Zucman-Rossi J. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat. Genet. 2012, 44:694-698.
103. Huang J., Deng Q., Wang Q., Li K.Y., Dai J.H., Li N., Zhu Z.D., Zhou B., Liu X.Y., Liu R.F., Fei Q.L., Chen H., Cai B., Zhou B., Xiao H.S., Qin L.X., Han Z.G. Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nat. Genet. 2012, 44:1117-1121.
104. Kan Z., Zheng H., Liu X., Li S., Barber T., Gong Z., Gao H., Hao K., Willard M.D., Xu J., Hauptschein R., Rejto P.A., Fernandez J., Wang G., Zhang Q., Wang B., Chen R., Wang J., Lee N.P., Zhou W., Lin Z., Peng Z., Yi K., Chen S., Li L., Fan X., Yang J., Ye R., Ju J., Wang K., Estrella H., Deng S., Wei P., Qiu M., Wulur I.H., Liu J., Ehsani M.E., Zhang C., Loboda A., Sung W.K., Aggarwal A., Poon R.T., Fan S.T., Hardwick J., Wang J., Reinhard C., Dai H., Li Y., Luk J.M., Mao M. Whole genome sequencing identifies recurrent mutations in hepatocellular carcinoma. Genome Res. 2013, 23:1422-1433.
105. Chen Y., Wang L., Xu H., Liu X., Zhao Y. Exome capture sequencing reveals new insights into hepatitis B virus-induced hepatocellular carcinoma at the early stage of tumorigenesis. Oncol. Rep. 2013, 30:1906-1912.
106. Chen L., Li Y., Lin C.H., Chan T.H., Chow R.K., Song Y., Liu M., Yuan Y.F., Fu L., Kong K.L., Qi L., Li Y., Zhang N., Tong A.H., Kwong D.L., Man K., Lo C.M., Lok S., Tenen D.G., Guan X.Y. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat. Med. 2013, 19:209-216.
107. Tischoff I., Tannapfe A. DNA methylation in hepatocellular carcinoma. World J. Gastroenterol. 2008, 14:1741-1748.
108. Jia D., Wei L., Guo W., Zha R., Bao M., Chen Z., Zhao Y., Ge C., Zhao F., Chen T., Yao M., Li J., Wang H., Gu J., He X. Genome-wide copy number analyses identified novel cancer genes in hepatocellular carcinoma. Hepatology 2011, 54:1227-1236.
109. Shitani M., Sasaki S., Akutsu N., Takagi H., Suzuki H., Nojima M., Yamamoto H., Tokino T., Hirata K., Imai K., Toyota M., Shinomura Y. Genome-wide analysis of DNA methylation identifies novel cancer-related genes in hepatocellular carcinoma. Tumour Biol. 2012, 33:1307-1317.
110. Shen J., Wang S., Zhang Y.J., Kappil M., Wu H.C., Kibriya M.G., Wang Q., Jasmine F., Ahsan H., Lee P.H., Yu M.W., Chen C.J., Santella R.M. Genome-wide DNA methylation profiles in hepatocellular carcinoma. Hepatology 2012, 55:1799-1808.
111. Levrero M., Pollicino T., Petersen J., Belloni L., Raimondo G., Dandri M. Control of cccDNA function in hepatitis B virus infection. J. Hepatol. 2009, 51:581-592.
112. Bock C.T., Schwinn S., Locarnini S., Fyfe J., Manns M.P., Trautwein C., Zentgraf H. Structural organization of the hepatitis B virus minichromosome. J. Mol. Biol. 2001, 307:183-196.
113. Bock C.T., Schranz P., Schroder C.H., Zentgraf H. Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell. Virus Genes 1994, 8:215-229.
114. Bonilla G.R., Roberts L.R. The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma. J. Hepatol. 2005, 42:760-777.
115. Neuveut C., Wei Y., Buendia M.A. Mechanisms of HBV-related hepatocarcinogenesis. J. Hepatol. 2010, 52:594-604.
116. Sung W.K., Zheng H., Li S., Chen R., Liu X., Li Y., Lee N.P., Lee W.H., Ariyaratne P.N., Tennakoon C., Mulawadi F.H., Wong K.F., Liu A.M., Poon R.T., Fan S.T., Chan K.L., Gong Z., Hu Y., Lin Z., Wang G., Zhang Q., Barber T.D., Chou W.C., Aggarwal A., Hao K., Zhou W., Zhang C., Hardwick J., Buser C., Xu J., Kan Z., Dai H., Mao M., Reinhard C., Wang J., Luk J.M. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat. Genet. 2012, 44:765-769.
117. Tokino T., Matsubara K. Chromosomal sites for hepatitis B virus integration in human hepatocellular carcinoma. J. Virol. 1991, 65:6761-6764.
118. Wang H.P., Rogler C.E. Topoisomerase I-mediated integration of hepadnavirus DNA in vitro. J. Virol. 1991, 65:2381-2392.
119. Pourquier P., Jensen A.D., Gong S.S., Pommier Y., Rogler C.E. Human DNA topoisomerase I-mediated cleavage and recombination of duck hepatitis B virus DNA in vitro. Nucleic Acids Res. 1999, 27:1919-1925.
120. Wang J., Chenivesse X., Henglein B., Brechot C. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature 1990, 343:555-557.
121. Murakami Y., Saigo K., Takashima H., Minami M., Okanoue T., Brechot C., Paterlini-Brechot P. Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut 2005, 54:1162-1168.
122. Dejean A., Sonigo P., Wain-Hobson S., Tiollais P. Specific hepatitis B virus integration in hepatocellular carcinoma DNA through a viral 11-base-pair direct repeat. Proc. Natl. Acad. Sci. U.S.A. 1984, 81:5350-5354.
123. Jiang Z., Jhunjhunwala S., Liu J., Haverty P.M., Kennemer M.I., Guan Y., Lee W., Carnevali P., Stinson J., Johnson S., Diao J., Yeung S., Jubb A., Ye W., Wu T.D., Kapadia S.B., de Sauvage F.J., Gentleman R.C., Stern H.M., Seshagiri S., Pant K.P., Modrusan Z., Ballinger D.G., Zhang Z. The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients. Genome Res. 2012, 22:593-601.
124. Hindorff L.A., MacArthur J., Morales J., Junkins H.A., Hall P.N., Klemm A.K., Manolio T.A. A Catalog of Published Genome-Wide Association Studies 2013, 18-9-2013, 10-9-2013. Ref. type: online source.